European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Cellobiose as a Candidate Prebiotic: Enhanced Butyrate Production in an In Vitro Human Gut Fermentation Model April 8, 2026 A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024 Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024
Cellobiose as a Candidate Prebiotic: Enhanced Butyrate Production in an In Vitro Human Gut Fermentation Model April 8, 2026
A Comprehensive Literature Review from 2012 to 2023 Examining Their Impact on Human Health Across Seven Major Conditions February 14, 2024
Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024